WHO and African CDC to declare dual public health emergencies for escalating mpox outbreak in Central Africa

The World Health Organization (WHO) is preparing to declare the mpox outbreak in central Africa a…

A new study highlights an elevated risk of severe skin reactions from commonly prescribed oral antibiotics

A recent study published in JAMA highlights the significant risks associated with commonly prescribed oral antibiotics…

Global meta-analysis confirms efficacy and safety of dengue vaccine

A recent global meta-analysis has confirmed the efficacy and safety of TAK-003, also known as Qdenga.…

Study shows urinary metals linked to increased cardiovascular disease and mortality risk

A recent study published in Circulation has revealed a significant association between urinary metal levels and…

New study links heteroresistance to fungal infections in transplant patients, proposes a diagnostic solution

Fungal infections during allogeneic hematopoietic cell transplantation (allo-HCT) represent a significant and often perplexing threat to…

Phase 3 trial shows the efficacy of benralizumab in eosinophilic esophagitis treatment

A recent phase 3 clinical trial has revealed significant findings on the efficacy and safety of…

Revolutionary granzyme B PET imaging offers real-time insight and precision in inflammatory bowel disease management

Granzyme B, a serine protease, is a key effector molecule in the immune system that facilitates…

New insights into MASH could revolutionize early diagnosis and treatment, reducing the need for liver transplants

One major contributor to the rise in liver disease is metabolic dysfunction-associated steatohepatitis (MASH), a severe…

Promising drug repurposing: tamsulosin, metoprolol, and bromocriptine as potential treatments for retinal degeneration

A team of researchers has unveiled promising results in the treatment of retinal degeneration through drug…

Study finds SGLT2 inhibitors significantly lower kidney and heart risks in patients with lupus and type 2 diabetes

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of medications primarily used to manage type 2 diabetes, have…

Don’t miss our updates!

We don’t spam! Read our [link]privacy policy[/link] for more info.